PHB2 and breast cancer: To further explore the specific mechanism by which LacRNA affects the stability of the PHB2 protein, breast cancer cells were treated with the proteasome inhibitor MG132 and the autophagy inhibitors chloroquine (CQ) and 3-methyladenine (3MA) (Fig. 5f).